Navigation Links
American Society of Clinical Oncology issues annual report on state of clinical cancer science
Date:12/3/2012

ALEXANDRIA, Va. The American Society of Clinical Oncology (ASCO) has just released its annual report on the top cancer advances of the year. Clinical Cancer Advances 2012: ASCO's Annual Report on Progress Against Cancer, highlights major achievements in precision medicine, cancer screening and overcoming treatment resistance.

"Consistent, significant achievements are being made in oncology care with novel therapeutics, even in malignancies that have previously had few treatment options, as well as defining factors that will predict for response to treatment. ASCO's report distills the most significant of these advances that are impacting the lives of cancer patients today," said Bruce Roth, MD, Co-Executive Editor of the report."

Many of the top clinical research advances of 2012 involve therapeutic approaches that stem from our growing understanding of the complex biology of cancer, which enables development of targeted drugs and treatments tailored to molecular characteristics of individual patients and their tumors. This research has led to seven new FDA approvals for anticancer agents in 2012, some of which will help patients with treatment-resistant forms of cancer.

The top cancer advances from this year include:

  • Two new therapies which delay progression of advanced breast cancer One study found adding targeted therapy to hormonal therapy delays disease progression in postmenopausal women with advanced hormone receptor-positive breast cancer
  • Another advance was an armed antibody or "smart bomb" approach called TDM-1 to selectively deliver medicine to HER2-positive breast cancer cells, leaving healthy cells alone
  • Research finding that pre-operative chemotherapy and radiation improves survival for patients with esophageal cancer
  • A study showing screening with flexible sigmoidoscopy reduces colorectal cancer incidence and death rates
  • Research showing a new targeted treatment extends survival for patients with advanced prostate cancer

The large number of advances featured in this year's report showcase the payoff of the national investment in clinical cancer research on prevention, screening, survival and quality of life for patients with cancer. The report, now in its eighth year, features 87 studies, 17 of which were designated as major advances by the report's 21-person editorial board.

This year's report also contains "The Policy Environment: ASCO in Action in 2012" section, which outlines some of the key cancer policy issues facing physicians and patients, including addressing the nation's cancer drug shortages and ensuring all patients have access to high-quality care. Additional topics covered in this section include ASCO's initiative to build a rapid learning system for oncology called CancerLinQ and the Society's recommendations for improving quality and value in cancer care through the Choosing Wisely campaign and ASCO's Top Five list.


'/>"/>
Contact: Susie Tappouni
susie.tappouni@asco.org
571-483-1333
American Society of Clinical Oncology
Source:Eurekalert

Related medicine news :

1. Clinical news alert from the American Academy of Orthopaedic Surgeons
2. American College of Cardiology cites new USF Simulation Center for Training Excellence
3. Presidential keynote address and new research highlights from the American Society of Pediatric Otolaryngology meeting
4. Young Americans Need to Cut Calorie Intake: Study
5. Hutchinson Center president elected to American Academy of Art and Sciences
6. Can weight loss help African-American breast cancer survivors?
7. Americans Support Medicare Reform, But Not on Their Dime: Poll
8. One-third of adult Americans with arthritis battle anxiety or depression
9. Equal access to care helps close survival gap for young African-American cancer patients
10. Systemic sclerosis complications more severe in African Americans than Caucasians
11. 53 million Americans might have diabetes by 2025, according to a new study in Population Health Management
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... ... February 05, 2016 , ... Give To Cure ... search for and donate to Give To Cure’s campaign that is crowdfunding clinical trials ... users make and share payments through a smart device. In 2015 alone, Venmo processed ...
(Date:2/5/2016)... ... February 05, 2016 , ... Pivot Point ... Best in KLAS: Software & Services for HIT Implementation Support & Staffing report ... independently ranks vendor performance by healthcare executives, managers and clinicians representing over 4,500 ...
(Date:2/5/2016)... ... February 05, 2016 , ... Dr. Justin Scott and Dr. ... Annual No Cost Dental Day to individuals in need. The event is scheduled to ... No Cost Dental Day is to provide dental care to community members in need. ...
(Date:2/5/2016)... ... February 05, 2016 , ... Dr. Ben Amini, a ... is now welcoming orthodontist, Dr. Amanda Cheng, to the practice. With the addition ... health care, including general dentistry, cosmetic treatments, periodontics, implant dentistry , endodontics, ...
(Date:2/5/2016)... ... February 05, 2016 , ... In sleep, when the ... a dream. A hallmark feature of patients with eating disorders is significant self-criticism, and ... disorder behaviors and obsessions are regarded as maladaptive means for coping with this unease, ...
Breaking Medicine News(10 mins):
(Date:2/5/2016)...  Venice,s newest laser clinic, Physicians Advanced ... kind in the area and specializes in the ... The physician-owned and operated laser clinic is taking ... with its revitalizing skin care approach, unprecedented eVisit ... technology. http://photos.prnewswire.com/prnh/20160204/329957 --> ...
(Date:2/5/2016)... , Feb. 5, 2016  Henry Schein, Inc. (NASDAQ: ... care products and services to office-based dental, animal health ... into an agreement to acquire a majority ownership interest ... and equipment in Brazil . ... in Blumenau, Brazil, Dental Cremer is the dental distribution business ...
(Date:2/4/2016)... Feb. 4, 2016  Edwards Lifesciences Corporation (NYSE: ... structural heart disease and critical care monitoring, announced today ... (ASR) agreement with Morgan Stanley & Co. LLC to ... is part of the Company,s previously authorized program to ... stock.  --> --> ...
Breaking Medicine Technology: